Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
NVO [NYSE]
Novo Nordisk A/S
Index- P/E26.72 EPS (ttm)1.72 Insider Own- Shs Outstand2.11B Perf Week1.39%
Market Cap96.80B Forward P/E22.67 EPS next Y2.03 Insider Trans- Shs Float1.52B Perf Month-0.20%
Income4.57B PEG2.23 EPS next Q- Inst Own9.00% Short Float0.22% Perf Quarter8.55%
Sales14.84B P/S6.52 EPS this Y20.30% Inst Trans4.28% Short Ratio3.74 Perf Half Y-0.26%
Book/sh2.47 P/B18.61 EPS next Y11.93% ROA39.10% Target Price49.37 Perf Year37.73%
Cash/sh0.55 P/C83.77 EPS next 5Y12.00% ROE68.20% 52W Range31.61 - 47.53 Perf YTD26.72%
Dividend0.61 P/FCF65.29 EPS past 5Y24.70% ROI56.40% 52W High-3.30% Beta0.97
Dividend %1.33% Quick Ratio1.00 Sales past 5Y12.90% Gross Margin83.30% 52W Low45.40% ATR0.54
Employees40226 Current Ratio1.40 Sales Q/Q1.20% Oper. Margin38.10% RSI (14)55.72 Volatility0.71% 1.00%
OptionableYes Debt/Eq0.01 EPS Q/Q6.80% Profit Margin30.90% Rel Volume0.98 Prev Close45.67
ShortableYes LT Debt/Eq0.00 EarningsFeb 02 BMO Payout33.80% Avg Volume889.40K Price45.96
Recom2.00 SMA201.92% SMA500.84% SMA2009.05% Volume875,847 Change0.63%
28-May-13Upgrade Deutsche Bank Sell → Hold
31-Mar-10Initiated Deutsche Bank Hold
30-Mar-10Downgrade Mehta Partners Outperform → Market Perform
24-Feb-10Upgrade Jefferies & Co Hold → Buy
15-Jan-10Downgrade Jefferies & Co Buy → Hold
11-Sep-09Initiated Jefferies & Co Buy
07-Aug-09Downgrade UBS Buy → Neutral
07-Aug-09Downgrade JP Morgan Overweight → Neutral
12-May-09Initiated Piper Jaffray Buy
24-Apr-09Upgrade Citigroup Hold → Buy
26-Mar-09Upgrade UBS Neutral → Buy
14-Jan-09Downgrade Citigroup Hold → Sell
06-Oct-08Upgrade Deutsche Securities Hold → Buy
29-Aug-08Downgrade Bernstein Mkt Perform → Underperform
21-Aug-08Initiated UBS Neutral
09-Jun-08Upgrade HSBC Securities Underweight → Neutral
26-Feb-08Downgrade Bear Stearns Outperform → Peer Perform
08-Feb-08Upgrade Bernstein Mkt Perform → Outperform
23-Jan-08Upgrade Bear Stearns Peer Perform → Outperform
09-Aug-07Downgrade Lehman Brothers Overweight → Equal-weight
29-Aug-14 03:30PM  Eli Lilly-Boehringer Drug's Cost Effectiveness Questioned Zacks
28-Aug-14 01:04PM  NVO, BMRN And ILMN, 3 Health Care Stocks Pushing The Sector Lower at TheStreet
27-Aug-14 06:16PM  [$$] Novo Nordisk CEO Has No Plans for Big Acquisitions at The Wall Street Journal
09:40AM  [$$] Novo Nordisk CEO Has No Plans for Big Acquisitions at The Wall Street Journal
08:32AM  [$$] Novo Nordisk CEO Has No Plans for Big Acquisitions at The Wall Street Journal
12:32AM  [$$] Novo Nordisk CEO Has No Plans for Big Acquisitions at The Wall Street Journal
12:15AM  [$$] Novo Nordisk CEO Has No Plans for Big Acquisitions at The Wall Street Journal
26-Aug-14 11:14PM  [$$] Novo Nordisk CEO Has No Plans for Big Acquisitions at The Wall Street Journal
09:15PM  [$$] Novo Nordisk CEO Has No Plans for Big Acquisitions at The Wall Street Journal
09:33AM  [$$] Novo Nordisk CEO Has No Plans for Big Acquisitions at The Wall Street Journal
25-Aug-14 12:09PM  Deal lifts Roche; Draghi boosts banks: Europes stock moves at MarketWatch
10:26AM  Deal lifts Roche; Draghi boosts banks: Europes stock moves at MarketWatch
06:08AM  Roche climbs on deal; banks higher: Europes stock moves at MarketWatch
19-Aug-14 04:50PM  Novo Nordisk to Pay Fine, Tresiba in Focus Zacks
18-Aug-14 02:58PM  Novo Nordisk Pays for a Weekend Delay at The Wall Street Journal
08-Aug-14 03:10PM  Novo Nordisk's Earnings Rise on Solid Victoza, Levemir Sales Zacks
07-Aug-14 06:50PM  Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide at Investor's Business Daily
12:04PM  Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats at Investor's Business Daily
02:29AM  [$$] Novo Nordisk's Net Profit Rises at The Wall Street Journal
29-Jul-14 07:15AM  Novo Nordisk Diabetes Drug Xultophy Gets Positive CHMP View Zacks
25-Jul-14 07:30AM  Novo Nordisk receives positive opinion from CHMP at theflyonthewall.com
07:23AM  EMA recommends approval for Novo Nordisk diabetes treatment at theflyonthewall.com
17-Jul-14 08:49AM  [video] Paying for diabetes pandemic at CNBC
16-Jul-14 01:03PM  3 Stocks Advancing The Drugs Industry at TheStreet
11-Jul-14 05:18PM  Is This MannKind's Greatest Risk? at Motley Fool
08-Jul-14 05:40PM  Sanofi's Basal Insulin Candidate Under FDA Review Zacks
10:30AM  Can Dividend Stocks Novo Nordisk and Novartis Continue to Perform? at Motley Fool
10:30AM  Novo Nordisk Gets FDA Nod for NovoSeven RT Zacks
07-Jul-14 06:18PM  Jazz, Novo Among Medicals Showing Healthy Action at Investor's Business Daily
05:03AM  1 Key Question Remains after MannKind's Giant Leap at Motley Fool
05-Jul-14 05:00PM  3 Things to Look for in MannKind's Partnership at Motley Fool
30-Jun-14 05:00PM  Biogen Hemophilia Drugs Launch Into The Unknown at Investor's Business Daily
04:32PM  MannKind's Afrezza Approved but Will Doctors Prescribe It? at Motley Fool
02:02PM  MannKind Stock: Afrezza Approved at Last, But Will Sales Disappoint? at Motley Fool
11:06AM  Up 9%: What You Need to Know About MannKind Today at Motley Fool
10:38AM  Consider Shire Pharmaceuticals Now; 20%+ Upside Left In Takeover Bid By AbbVie at Seeking Alpha
27-Jun-14 02:22AM  MannKind's Clock Is Ticking, But Balance Sheet Sounds An Alarm at Seeking Alpha
02:22AM  MannKind's Clock Is Ticking, But Balance Sheet Sounds An Alarm
26-Jun-14 06:41PM  Novo, Other Medicals Display Healthy Action at Investor's Business Daily
06:41PM  Novo, Other Medicals Display Healthy Action
06:05PM  Novo Nordisk's Diabetes Pill Shows Promise at Seeking Alpha
06:05PM  Novo Nordisk's Diabetes Pill Shows Promise
24-Jun-14 11:00AM  Team Novo Nordisk, the world's first all-diabetes professional cycling team, races in BC Superweek CNW Group
11:00AM  Team Novo Nordisk, the world's first all-diabetes professional cycling team, races in BC Superweek
01:11AM  Is Sanofi's Dividend Safe? at Motley Fool
01:11AM  Is Sanofi's Dividend Safe?
23-Jun-14 04:32PM  Sanofi: Toujeo Is Not The Ace In Its Deck at Seeking Alpha
04:32PM  Sanofi: Toujeo Is Not The Ace In Its Deck
10:30AM  Novo Nordisk Reveals Positive Data on Victoza 3 mg Zacks
10:30AM  Novo Nordisk Reveals Positive Data on Victoza 3 mg
12:01AM  Early Results Arrive on Weight-Loss Pills That Expand in the Stomach at New York Times
12:01AM  Early Results Arrive on Weight-Loss Pills That Expand in the Stomach
20-Jun-14 06:24PM  Who Will Win This $45 Billion Market? at Motley Fool
06:24PM  Who Will Win This $45 Billion Market?
02:32PM  Health Insurers Pressing Down on Drug Prices at New York Times
02:32PM  Health Insurers Pressing Down on Drug Prices
11:34AM  The Anti-Obesity Space Is Not As Simple As Some Think at Seeking Alpha
11:34AM  The Anti-Obesity Space Is Not As Simple As Some Think
18-Jun-14 04:34PM  Is Novo Nordisk's Dividend Safe? at Motley Fool
04:34PM  Is Novo Nordisk's Dividend Safe?
03:30PM  A Cost of Doing Business? How Regulatory Fines Hurt Shareholder Returns at The Wall Street Journal
03:30PM  A Cost of Doing Business? How Regulatory Fines Hurt Shareholder Returns
08:46AM  Novo Nordisk (NVO) is in Overbought Territory: What's Next? Zacks
08:46AM  Novo Nordisk (NVO) is in Overbought Territory: What's Next?
17-Jun-14 03:35PM  Ligand Pharma's LGD-6972 Positive in Phase I Study Zacks
03:35PM  Ligand Pharma's LGD-6972 Positive in Phase I Study
12:34AM  [$$] Novo Nordisk Sees 'No Strategic Reason' For Big Mergers at The Wall Street Journal
12:34AM  [$$] Novo Nordisk Sees 'No Strategic Reason' For Big Mergers
16-Jun-14 11:15PM  [$$] Novo Nordisk Sees 'No Strategic Reason' For Big Mergers at The Wall Street Journal
09:13PM  [$$] Novo Nordisk Sees 'No Strategic Reason' For Big Mergers at The Wall Street Journal
03:45PM  Novo Nordisk's Victoza 3 mg Positive in Phase III Zacks
03:45PM  Novo Nordisk's Victoza 3 mg Positive in Phase III
03:30PM  Sanofi's Diabetes Portfolio in Focus at American Diabetes Association Sessions Zacks
03:30PM  Sanofi's Diabetes Portfolio in Focus at American Diabetes Association Sessions
10:10AM  Eli Lilly Impresses at American Diabetes Association Sessions Zacks
10:10AM  Eli Lilly Impresses at American Diabetes Association Sessions
07:25AM  [$$] Novo Nordisk Sees 'No Strategic Reason' For Big Mergers at The Wall Street Journal
06:52AM  [$$] Novo Nordisk Sees 'No Strategic Reason' For Big Mergers at The Wall Street Journal
15-Jun-14 03:48PM  Will These 3 Products Revolutionize Diabetes Treatment? at Motley Fool
14-Jun-14 01:27AM  The 3 Best Big Pharma Dividend Stocks of the Past 10 Years at Motley Fool
13-Jun-14 05:29PM  Novo Nordisk Raises Insulin Prices As Demand Grows at Investor's Business Daily
02:56PM  Vivus Suit Preserves Exclusivity Of Qsymia - For Now at Seeking Alpha
01:41PM  [video] The diabetes battleground at CNBC
09:24AM  Is Eli Lilly's Dividend Safe? at Motley Fool
09:22AM  Stock Downgrades: Another Kick in the Pants for Lululemon at Minyanville
11-Jun-14 07:46PM  MannKind Corporation's Date With Destiny at Motley Fool
10-Jun-14 01:02PM  Today's Stocks Driving Success For The Health Care Sector at TheStreet
06-Jun-14 11:33AM  5 Toxic Big Pharma Stocks You Need to Sell This Summer at TheStreet
07:00AM  MannKind Hits 52-Week High Zacks
04-Jun-14 07:00AM  Qu├ębec Becomes First Province to Add Victoza┬« to the Drug Benefit Formulary* for the Treatment of Type 2 Diabetes PR Newswire
03-Jun-14 06:32PM  The Importance Of Being Oral at Seeking Alpha
27-May-14 06:32PM  Is Biogen Idec Inc a Buy? at Motley Fool
23-May-14 11:45AM  Novo Nordisk to host conference call at theflyonthewall.com
22-May-14 08:01AM  Norway's Exemplary Gender Quota? Just Don't Ask About CEOs at The Wall Street Journal
21-May-14 04:35PM  FDA Panel to Review Novo Nordisk's Victoza 3mg Zacks
20-May-14 08:20AM  Citigroup to hold a conference at theflyonthewall.com
19-May-14 04:39PM  Investors Should Cheer Novo Nordisk Study Results at Seeking Alpha
16-May-14 04:30PM  Data on Novo Nordisk's NovoEight Zacks
14-May-14 07:12AM  Novo Nordisk downgraded to Neutral from Buy at UBS at theflyonthewall.com
13-May-14 10:10AM  Wider-than-Expected Q1 Loss at MannKind Zacks
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.